|Articles|June 15, 2004
Phakic IOL preserves endothelial cell count outcome measure
Study shows cell loss equal to natural aging, allowing IOL to be implanted in young patients
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Seeing the difference: Multimodal imaging for AMD and GA
2
Spotlight on women's health: Understanding thyroid eye disease
3
Strategic approaches optimize teaching and learning in the clinic
4
FDA extends Aldeyra's reproxalap PDUFA after requesting additional clinical study report
5




































